Lupin
₹1,961.6-19.30 (-0.97%)as of 2026-10-16
- Market Cap
- ₹90,899Cr.
- P/E Ratio
- 15.3
- P/B Ratio
- 4.00
- EPS (TTM)
- ₹128.21
- Day Range
- ₹1,947 – ₹1,980.5
- Div Yield
- 0.92%
- ROCE
- 29.9%
- ROE
- 28.7%
52W Low: ₹1,90052W High: ₹2,530
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 19.0% a year over three years.
- Debt is 0.29× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Lupin — Price
Interval
Style
Failed: 503
Evenstocks Score
Upper third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 15.3P/E: 15.3 | P/B: 4.00Growth
GrowingSales CAGR — 3Y: 19% · 1Y: 28%Profitability
High MarginROCE: 29.9% | ROE: 28.7%Key Metrics
Valuation
PEG Ratio 0.11
Price / Sales 3.03x
Price / FCF 16.4x
Book Value ₹491
Margins & returns
Operating Margin 32%
Net Margin 18.5%
Return on Assets 14.6%